Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) infection and have more
severe disease, and carotid atherosclerosis is an early lesion in IS. Methods
Korneyev, I.A.,
Alexeeva, T.A.,
Al-Shukri, S.H.,
Bernikov, A.N.,
Erkovich, A.A.,
Kamalov, A.A.,
Kogan, M.I.,
Pavlov, V.N.,
Zhuravlev, V.N.,
Pushkar, D.Y. (2016) in 530 (48.9%) men, consisting of mild and mild to moderate, moderate and
severe ED in 375 (34.6%), 78 (7
GORDEEVA, A.V.,
SITDIKOVA, I.D.,
GALIMOVA, I.A.,
GUREVSKAYA, O.А.,
USMANOVA, I.N.,
DETOCHKINA, V.R. (2019) of remission of the disease, and reducing the rate of relapses and the
severity of clinical manifestations
СЛУЧАЙ ЯТРОГЕННОГО БОТУЛИЗМА ПРИ БОТУЛИНОТЕРАПИИ В КЛИНИЧЕСКОЙ ПРАКТИКЕ. Extremely rare but
severe complication of botulinotherapy (BT) is a condition, which is associated
the disadvantages of a global cornea shortage, graft failure, and
severe side effects. There is a recognized need
Introduction: Due to
severe burden of depressive disorders and a low rate of remission in patients
Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) For
several decades, research in tumor biology has focused on the involvement of genes encoding a
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) ICTRP up to 11 November 2022. Our primary outcome was fatigue
severity. We conducted subgroup analysis